David E. Gauden, D.Phil. is CEO of Blue Earth Therapeutics and CEO and co-founder of Blue Earth Diagnostics. He has more than 20 years of industry expertise in radiopharmaceuticals and diagnostic medical imaging. Dr. Gauden has served as Product Leader for oncology molecular imaging at GE Healthcare, with business responsibility for the product portfolio, licensing, product development and strategic marketing activities across a range of developmental PET drugs. Dr. Gauden holds an undergraduate degree from the University of Warwick and a doctorate in Biochemistry from the University of Oxford.